课题基金 / 基金详情

FULL LENGTH REPRESENTATIONAL CDNA LIBRARY ENRICHMENT

FULL LENGTH REPRESENTATIONAL CDNA LIBRARY ENRICHMENT
全长代表性 CDNA 文库富集
批准号:
6072254
负责人:
Frederick S Hagen
金额:
$0.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-09-30 至 1999-09-29

项目摘要

项目成果

Frederick S Hagen的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Applicant's Description) Cancer will affect one out of every three Americans in their lifetime. Even though advances in research and medicine have given us a greater understanding of cancer it has also revealed the great complexity of this disease. Towards a greater understanding of neoplasms and the formation of neoplastic tissue, there is an interest in the identification of all expressed genetic information of neoplastic cells and to compare this to expressed genetic information in normal cells. This application describes proposed research for the development of innovative technologies for the efficient generation of representational full length cDNA libraries and for the normalization and subtractive enrichment of these libraries. Full Length cDNAs are those clones that contain a copy of the entire mRNA sequence from which they were derived. Representational libraries are libraries that contain at least one cDNA for every mRNA species present in the starting tissue. Of the mRNAs in a typical cell, the prevalent and intermediate frequency classes comprise between 50 to 65 % of the total mRNA mass while representing only about 1000 to 2000 different mRNAs. Redundant identification of mRNAs of these two frequency classes is destined to become overwhelming in a random cDNA discovery program. Thus it is very useful to be able to construct normalized and subtracted libraries. Normalized libraries are libraries which contain a near molar equivalent copy of each mRNA transcript of the RNA source. Subtracted libraries are libraries which contain clones representing the difference between two sources of RNA. The development of these technologies will provide tools for the many investigators who have as their goal the further understanding of the generation of neoplasms and the development of methods for the treatment of these diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Substrate Based Proteolytic Inhibitors for the Treatment of Huntington's Disease
  • 批准号:
    7848669
  • 项目类别:
  • 资助金额:
    $0.93万
  • 财政年份:
    2009
  • 负责人:
    Frederick S Hagen
  • 依托单位:
Substrate Based Proteolytic Inhibitors for the Treatment of Huntington's Disease
  • 批准号:
    7611899
  • 项目类别:
  • 资助金额:
    $36.19万
  • 财政年份:
    2009
  • 负责人:
    Frederick S Hagen
  • 依托单位:
Alzheimer's Therapeutic Derived from a Natural Product
  • 批准号:
    6889384
  • 项目类别:
  • 资助金额:
    $36.91万
  • 财政年份:
    2005
  • 负责人:
    Frederick S Hagen
  • 依托单位:
Effector of APP to Lower Amount of beta-Amyloid Protein
  • 批准号:
    6648997
  • 项目类别:
  • 资助金额:
    $36.99万
  • 财政年份:
    2003
  • 负责人:
    Frederick S Hagen
  • 依托单位:
国内基金
海外基金
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
  • 批准号:
    32302245
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    潘寒姁
  • 依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
  • 批准号:
    82371775
  • 项目类别:
    面上项目
  • 资助金额:
    46万元
  • 批准年份:
    2023
  • 负责人:
    朱慧媛
  • 依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
  • 批准号:
    31871817
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2018
  • 负责人:
    孙爱东
  • 依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
  • 批准号:
    81873549
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    刘玉兰
  • 依托单位: